Treatment of Clostridium difficile infection

The Journal of Antimicrobial Chemotherapy
M H Wilcox

Abstract

The treatment options for Clostridium difficile infection remain limited, although promising agents are currently being assessed. Metronidazole is the first-line drug of choice for those patients requiring specific anti-C. difficile treatment. Much of the interest in alternative therapies has centred on the difficult management issues posed by patients with multiple symptomatic recurrences of C. difficile infection. However, it is now clear that the majority of these episodes are due to reinfections with new C. difficile strains and not relapses caused by the original bacterium. Hence, the true efficacy of the alternative regimens remains unclear. Individuals susceptible to C. difficile reinfections need to be protected from exposure to C. difficile until their bowel flora recovers. While several biotherapeutic approaches to the treatment and prevention of C. difficile infection have been described, few controlled data are available. Preliminary studies with anti-C. difficile bovine immunoglobulin concentrates for treatment and prevention have produced promising results. Vaccination to prevent C. difficile infection, particularly in high-risk elderly patients managed within institutions where C. difficile is endemic, is a worth...Continue Reading

Citations

Sep 12, 2000·Current Gastroenterology Reports·C S Alcantara, R L Guerrant
Nov 30, 2000·Current Treatment Options in Gastroenterology·C M Surawicz, L V McFarland
Feb 21, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Johannes AasJohan S Bakken
Jul 9, 2008·The Journal of Antimicrobial Chemotherapy·Rachael O'ConnorMark H Wilcox
Oct 18, 2002·Antimicrobial Agents and Chemotherapy·Larbi DridiJean-Claude Petit
Oct 12, 2000·Clinical Microbiology Reviews·M A Keller, E R Stiehm
Sep 29, 2001·Journal of Clinical Pathology·N Modi, M H Wilcox
May 10, 2001·Journal of the American Veterinary Medical Association·J S WeeseH R Staempfli
Oct 16, 2008·The American Journal of Gastroenterology·M Raffat JaberMark E Reeves
Jul 24, 2002·The American Journal of Gastroenterology·Lynne V McFarlandChristina M Surawicz
Feb 8, 2003·Der Urologe. Ausg. A·C GrebT Kälble
Feb 13, 2002·Journal of Pediatric Gastroenterology and Nutrition·S Schmitt-GrohéS Zielen
Jul 2, 1999·Antimicrobial Agents and Chemotherapy·J Samuelson
Jun 2, 2000·Journal of Clinical Microbiology·F BarbutJ C Petit
Oct 6, 2001·Gastroenterology Clinics of North America·L KyneC P Kelly
Nov 9, 2010·Advances in Pediatrics·E Richard StiehmHeather Lehman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.